{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:21:30Z","timestamp":1776482490981,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1023\/a:1015504632021","type":"journal-article","created":{"date-parts":[[2003,3,15]],"date-time":"2003-03-15T13:06:01Z","timestamp":1047733561000},"page":"139-142","source":"Crossref","is-referenced-by-count":83,"title":["Do NSAIDs Affect the Progression of Osteoarthritis?"],"prefix":"10.1007","volume":"26","author":[{"given":"Changhai","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"373042_CR1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9","volume":"41","author":"D. T. Felson","year":"1998","unstructured":"Felson, D. T. and Y. Zhang. 1998. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheumatol.\n41: 1343\u20131355.","journal-title":"Arthritis Rheumatol."},{"key":"373042_CR2","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I","volume":"43","author":"M. B. Goldring","year":"2000","unstructured":"Goldring, M. B. 2000. The role of the chondrocyte in osteoarthritis.Arthritis Rheumatol.\n43: 1916\u20131926.","journal-title":"Arthritis Rheumatol."},{"issue":"1a","key":"373042_CR3","doi-asserted-by":"crossref","first-page":"8s","DOI":"10.1016\/S0002-9343(00)00628-8","volume":"110","author":"A. P. S. Hungin","year":"2001","unstructured":"Hungin, A. P. S. and D. W. F. Kean. 2001. Nonsteroidal antiin-flammatory drugs: overused or underused in osteoarthritis? Am. J.Med.\n110(1a): 8s\u201311s.","journal-title":"Am. J.Med."},{"key":"373042_CR4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/sj.bjp.0703710","volume":"131","author":"L. Blot","year":"2000","unstructured":"Blot, L., A. Marcelis, J. P. Devogelaer, and D. P. Manicourt. 2000.Effects of diclofenac, aceclofenac and meloxicam on metabolism of proteoglycans and hyaluronan in osteoarthritis human cartilage.Br. J. Pharmacol.\n131: 1413\u20131421.","journal-title":"Br. J. Pharmacol."},{"issue":"1Suppl22","key":"373042_CR5","first-page":"S7","volume":"19","author":"P. Mukherjee","year":"2001","unstructured":"Mukherjee, P., C. Rachita, P. S. Aisen, and G. M. Pasinetti. 2001.Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death. Clin. Exp. Rheumatol.\n19(1 Suppl 22): S7\u201311.","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"373042_CR6","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.165.6.3402","volume":"165","author":"K. D. Notoya","year":"2000","unstructured":"Notoya K, D. V. Jovanovic, and P. Reboul et al. 2000. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J. Immunol.\n165(6): 3402\u20133410.","journal-title":"J. Immunol"},{"key":"373042_CR7","first-page":"47","volume":"16","author":"J. Dingle","year":"1996","unstructured":"Dingle, J. 1996. Effects of NSAIDs on human articular glycosaminoglycan synthesis. Eur. J. Rheu. Inflam.\n16: 47\u201352.","journal-title":"Eur. J. Rheu. Inflam."},{"key":"373042_CR8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/joca.1998.0197","volume":"7","author":"Y. Henrotin","year":"1999","unstructured":"Henrotin, Y. and T. Y. Reginster. 1999. In vitro differences among nonsteroidal antiinflammatory drugs in their activities related to osteoarthritis pathophysiology. Osteoarthritis Cartilage.\n7: 355\u2013357.","journal-title":"Osteoarthritis Cartilage"},{"key":"373042_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/joca.1998.0195","volume":"7","author":"U. Serni","year":"1999","unstructured":"Serni U., A. Mannoni, and M. Benucci. 1999. Is there preliminary in-vivo an influence of nonsteroidal antiinflammatory drug treatment on osteoarthritis progression? Part II-evidence from animal models. Osteoarthritis Cartilage.\n7: 351\u2013352.","journal-title":"Osteoarthritis Cartilage"},{"key":"373042_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01972768","volume":"39","author":"A. Ratcliffe","year":"1993","unstructured":"Ratcliffe, A., M. P. Rosenwasser, and F. Mahmud et al. 1993. The in vivo effects of naproxen on canine experimental osteoarthritic articular cartilage: composition, metalloproteinase activities and metabolism. Agents Actions Suppl.\n39: 207\u2013211.","journal-title":"Agents Actions Suppl."},{"issue":"12","key":"373042_CR11","first-page":"2893","volume":"27","author":"J. P. Pelletier","year":"2000","unstructured":"Pelletier J. P., D. Lajeunesse, and D. V. Jovanovic et al. 2000.Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J. Rheumatol.\n27(12): 2893\u20132902.","journal-title":"J. Rheumatol"},{"issue":"2","key":"373042_CR12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.1780400213","volume":"40","author":"J. C. Fernandes","year":"1997","unstructured":"Fernandes J. C., J. P. Caron, and J. Martel-Pelletier et al. 1997.Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity. Arthritis Rheum.\n40(2): 284\u2013294.","journal-title":"Arthritis Rheum."},{"key":"373042_CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(24)34934-1","volume":"290","author":"C. Chan","year":"1999","unstructured":"Chan C. C., S. Boyce, and C. Brideau et al. 1999. Rofecoxib: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol. Exp. Ther.\n290: 551\u2013560.","journal-title":"J Pharmacol. Exp. Ther."},{"issue":"3","key":"373042_CR14","first-page":"215","volume":"200","author":"B. E. Gencosmanoglu","year":"2001","unstructured":"Gencosmanoglu, B. E., M. Eryavuz, and S. Dervisoglu. 2001.Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis. Res.Exp. Med. 200(3): 215\u2013226.","journal-title":"Res.Exp. Med."},{"key":"373042_CR15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(89)90651-X","volume":"2","author":"S. Rashad","year":"1989","unstructured":"Rashad S., P. Revell, and A. Hemingway et al. 1989. Effect of non steroidal antiinflammatory drugs on the course of osteoarthritis.Lancet.\n2: 519\u2013522.","journal-title":"Lancet"},{"key":"373042_CR16","first-page":"1941","volume":"22","author":"E. C. Huakinsson","year":"1995","unstructured":"Huakinsson E. C., H. Berry, and P. Gishen et al. on behalf of the LINK study group. 1995. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. J. Rheumatol.\n22: 1941\u20131946.","journal-title":"J. Rheumatol"},{"key":"373042_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/rheumatology\/32.7.595","volume":"32","author":"P. Dieppe","year":"1993","unstructured":"Dieppe P., J. Cushnaghan, and M. K. Jasani et al. 1993. A twoyear, placebo-controlled trial of non-steroidal nonantiflammatory therapy in osteoarthritis of the knee joint. Br. J. Rheumatol.\n32: 595\u2013600.","journal-title":"Br. J. Rheumatol"},{"key":"373042_CR18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.1780360904","volume":"36","author":"H. J. Williams","year":"1993","unstructured":"Williams H. J., J. R. Ward, and M. J. Egger et al. 1993. Comparison of naproxen and acetaminophen in a two-year study of the treatment of osteoarthritis of the knees. Arthritis Rheum.\n36: 1196\u20131206.","journal-title":"Arthritis Rheum."},{"issue":"4","key":"373042_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00045391-199907000-00003","volume":"6","author":"S. Sharma","year":"1999","unstructured":"Sharma S., S. Rastogi, V. Gupta, D. Rohtagi, and P. Gulati. 1999.Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection. Am.J. Ther.\n6(4): 191\u2013197.","journal-title":"Am.J. Ther."},{"key":"373042_CR20","doi-asserted-by":"crossref","unstructured":"Recommendations for the registration of drugs used in the treatment of osteoarthritis. 1996. Ann. Rheu. Dis.\n55: 552\u2013557.","DOI":"10.1136\/ard.55.8.552"},{"key":"373042_CR21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/joca.1998.0215","volume":"7","author":"J. P. Pelletier","year":"1999","unstructured":"Pelletier, J. P. 1999. The influence of tissue cross-talking on OA progression: Role of nonsteroidal antiinflammatory drugs.Osteoarthritis Cartilage.\n7: 374\u2013376.","journal-title":"Osteoarthritis Cartilage"},{"key":"373042_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5694\/j.1326-5377.1996.tb122200.x","volume":"164","author":"P. Mcmanus","year":"1996","unstructured":"Mcmanus P., J. G. Pimrose, and D. A. Henry et al. 1996. Pattern of non-steroidal antiinflammatory drug in Australia 1990\u20131994. Med.J. Aust.\n164: 589\u2013592.","journal-title":"Med.J. Aust."},{"issue":"3A","key":"373042_CR23","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1016\/S0002-9343(00)00680-X","volume":"110","author":"P. E. Lipsky","year":"2001","unstructured":"Lipsky, P. E. 2001. Recommendation for the clinical use of cyclooxygenase-2-specificied inhibitors. Am. J. Med.\n110(3A): 3s\u20135s.","journal-title":"Am. J. Med."},{"issue":"11","key":"373042_CR24","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/1529-0131(200011)43:11<2543::AID-ANR23>3.0.CO;2-K","volume":"43","author":"G. Jones","year":"2000","unstructured":"Jones G., M. Glisson, K. Hynes, and F. Cicuttini. 2000. Sex and site differences in cartilage development: a possible explanation for variations in knee osteoarthritis in later life. Arthritis Rheum.\n43(11): 2543\u20132549.","journal-title":"Arthritis Rheum."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015504632021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015504632021\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015504632021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:56:35Z","timestamp":1748264195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015504632021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["373042"],"URL":"https:\/\/doi.org\/10.1023\/a:1015504632021","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}